These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7455978)

  • 21. Evaluation of chromogenic substrate assays for fibrinolytic analytes in dogs.
    Lanevschi A; Kramer JW; Greene SA; Meyers KM
    Am J Vet Res; 1996 Aug; 57(8):1124-30. PubMed ID: 8836361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Coagulation properties of the extravascular fluid. II. Components of the fibrinolytic system in thoracic-duct lymph].
    Müller N; Danckworth HP
    Z Lymphol; 1980 Jul; 4(1):18-20. PubMed ID: 7456636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complex congenital malformations and the impact of the plasminogen activator system and beta-hCG in amniotic fluid.
    Verkleij-Hagoort AC; Ursem NT; Hop WC; Geurts-Moespot A; Steegers EA; Sweep FC; Steegers-Theunissen RP
    Eur J Obstet Gynecol Reprod Biol; 2007 Nov; 135(1):47-52. PubMed ID: 17141398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Physiological study of the fibrinolytic system in the joint].
    Kira S
    Nihon Seikeigeka Gakkai Zasshi; 1966 Oct; 40(7):1011-3. PubMed ID: 6010239
    [No Abstract]   [Full Text] [Related]  

  • 25. [Fibrinolytic activity of the placenta and in fetal death during pregnancy].
    Uszyński M; Uszyńska-Folejewska R
    Ginekol Pol; 1967 Mar; 38(3):279-82. PubMed ID: 6046500
    [No Abstract]   [Full Text] [Related]  

  • 26. Coagulation and fibrinolytic activity in patients with acute cerebral infarction.
    Li F; Zhang G; Zhao W
    Chin Med J (Engl); 2003 Mar; 116(3):475-7. PubMed ID: 12781064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fibrinolytic system in patients with myocardial infarction and other coronary disease risk factors].
    Moreno JA; Gálvez MM; Cornudella R; Angós JA; Romero MS; Gutiérrez M
    Sangre (Barc); 1994 Apr; 39(2):111-6. PubMed ID: 8059288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship of urokinase type plasminogen activator, plasminogen activator inhibitor type 1 and activated protein C in fibrinolysis of human placenta.
    Moniwa N
    Pol J Pharmacol; 1996; 48(2):215-20. PubMed ID: 9112654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrinolytic activity in dogs after surgically induced trauma.
    Lanevschi A; Kramer JW; Greene SA; Meyers KM
    Am J Vet Res; 1996 Aug; 57(8):1137-40. PubMed ID: 8836363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Apropos of the fibrinolytic system of the human amnionic fluid].
    Uszyński M; Uszyńska-Folejewska R
    Ginekol Pol; 1965 Oct; 36(10):1107-12. PubMed ID: 5854808
    [No Abstract]   [Full Text] [Related]  

  • 31. Coagulation and fibrinolysis in viable mid-trimester pregnancies of normal, intrauterine growth retardation, chromosomal anomalies and hydrops fetalis and their eventual obstetric outcome.
    Koh SC; Anandakumar C; Biswas A
    J Perinat Med; 1999; 27(6):458-64. PubMed ID: 10732304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
    Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endogenous testosterone, fibrinolysis, and coronary heart disease risk in hyperlipidemic men.
    Glueck CJ; Glueck HI; Stroop D; Speirs J; Hamer T; Tracy T
    J Lab Clin Med; 1993 Oct; 122(4):412-20. PubMed ID: 8228555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired fibrinolytic potential related to elevated alpha1-proteinase inhibitor levels in patients with pulmonary thromboembolism.
    Gombás J; Kolev K; Tarján E; Machovich R
    Ann Hematol; 2004 Dec; 83(12):759-63. PubMed ID: 15316758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombin activatable fibrinolysis inhibitor (TAFI) in human amniotic fluid. A preliminary study.
    Uszyński W; Uszyński M; Zekanowska E
    Thromb Res; 2007; 119(2):241-5. PubMed ID: 16540154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Functions of the amnion in the amniotic fluid/fetus compartment. A contribution to the problem of the origin of the lipids in the amniotic fluid (author's transl)].
    Schmidt W; Klima G
    Z Geburtshilfe Perinatol; 1980 Aug; 184(4):248-54. PubMed ID: 7467633
    [No Abstract]   [Full Text] [Related]  

  • 37. [Studies on the question of fibrinolytic factors in the placenta].
    Halberstadt E; Stein WW; Michel RT; Glück W
    Arch Gynakol; 1968; 206(4):450-5. PubMed ID: 5306076
    [No Abstract]   [Full Text] [Related]  

  • 38. Platelet (dys)function and plasma plasminogen levels in hemodialysis patients.
    Salobir B; Sabovic M; Zupan IP; Ponikvar JB
    Ther Apher Dial; 2008 Apr; 12(2):133-6. PubMed ID: 18387161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urokinase plasminogen activator (uPA) and its receptor (uPAR) in gestational tissues; Measurements and clinical implications.
    Uszyński M; Perlik M; Uszyński W; Zekanowska E
    Eur J Obstet Gynecol Reprod Biol; 2004 May; 114(1):54-8. PubMed ID: 15099871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors affecting the amniotic fluid excretory products.
    Mistry KP; Bhatt RV; Modi UJ; Shah MC
    Indian Pediatr; 1981 Dec; 18(12):883-9. PubMed ID: 7343482
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.